Background and Purpose-Case mix adjustment is required to allow valid comparison of outcomes across care providers.
D
espite improvements in the prognosis of acute stroke seen during the past 20 years, 1 it remains a condition with a high early mortality, with a risk of death of between 10% and 30% in the 30 days after stroke. 2, 3 In predicting outcomes after stroke, a variety of models have been developed that use information about patient characteristics to predict mortality and disability outcomes. [4] [5] [6] These models may be used to inform decision making, provide more accurate estimates of prognosis, plan services, and to facilitate risk-adjusted comparisons between care providers. Patients, the public, clinicians, healthcare funders, and politicians are increasingly demanding to know that care provision is of high quality and therefore asking to be able to compare outcomes between providers. It is essential that if mortality is publicly reported there should be confidence that the data are accurately adjusted for case mix variability and that the differences genuinely reflect variations in care.
We aimed to develop and validate a model to predict the 30-day risk of death after admission with acute stroke from a large, prospective data set of unselected cases of acute stroke admitted to hospitals in England and Wales. The primary rationale was to use the resulting model to enable reporting of case mix-adjusted mortality outcomes for stroke services. None of the previously published algorithms were considered
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suitable because they were validated in either ischemic stroke 5 or primary intracerebral hemorrhage (ICH), 7 rather than both, had methodological weaknesses such as lack of external validation 8 or included variables not available in the national stroke register of England and Wales. This illustrates a common problem with clinical prognostic models that they use variables available only in particular data sets, which are not routinely collected elsewhere, limiting their generalizability to other settings. Our aim was therefore to develop and validate prognostic models that were parsimonious, simple to calculate, and limited to commonly collected variables.
Methods

Data Sources
Data were drawn from 2 sources: The Sentinel Stroke National Audit Program (SSNAP), the national stroke register of England and Wales, 9 and the South London Stroke Register (SLSR). SSNAP is a prospectively collected register of patients admitted to hospital with acute stroke in England and Wales. Data are entered by clinical teams using a secure online web portal with built-in validation and data checking. Variables include demographic details, stroke phenotype, comorbidities, process of care, and clinical outcomes. Mortality status is identified by record linkage with the statutory national register of deaths. Data linkage was performed by a secure third party and the investigators were provided with an anonymized data set following removal of patient identifiers. Case ascertainment from stroke centers was estimated by comparison with stroke coding in administrative returns. Patients aged ≥18 years admitted with acute ischemic stroke or primary ICH from January 1, 2013 to June 30, 2013 were included in the data set. The data set was split at random into a derivation (one third) and an internal validation (two thirds) samples.
Data for external validation was drawn from the SLSR, a population-based study of all people with first-ever stroke in a defined population (357 308 inhabitants in 2010) of South London. 10 Patients with stroke are identified using multiple overlapping sources of notification and reviewed at the time of stroke by a trained field worker. Detailed methods are published elsewhere. 10 Patients aged ≥18 years admitted to hospital with ischemic stroke or primary ICH from 2005 to 2012 and with a documented National Institutes of Health Stroke Severity Score (NIHSS) on admission were included. Patients with subarachnoid hemorrhage were excluded from the analysis because they have a different clinical pathway and distinct epidemiology.
Statistical Analysis
The prognostic model was developed from the derivation sample (n=9000) and subsequently validated in the internal (n=18 169) and external (n=1470) validation data sets. Univariable associations between patient characteristics and 30-day mortality were assessed using χ 2 tests for categorical variables and Mann-Whitney tests for continuous variables. Continuous variables were described as medians with interquartile range.
The mortality model was fitted to the derivation data set using a process of backward elimination. The selection of the variables for initial inclusion was done following a literature review of stroke epidemiology and previously published stroke mortality models. A literature search for previously published models was performed in Pubmed using the following terms: Stroke AND (Mortality OR Death) AND Prediction. In addition to primary studies describing the derivation and validation of stroke mortality models, the search identified 1 systematic review. 4 Variables available in both data sets and identified from previously published mortality models included demographic details (age, sex), stroke type, mode of admission, prestroke functional level, stroke severity (NIHSS, level of consciousness), and cardiovascular comorbidity (diabetes mellitus, congestive cardiac failure, hypertension, atrial fibrillation, previous stroke, or transient ischemic attack). Data of noncardiovascular comorbidities were not available in the derivation data set. The models were fitted using general estimating equations with logit links, taking into account clustering at the hospital level. Analytic 95% confidence intervals were computed. Various methods of handling continuous variables were assessed, including nonlinear transformations and categorization. Age was nonlinearly associated with mortality risk and was included as a 5-level categorical variable in the final models. Inclusion of the NIHSS as a continuous predictor produced better model fit than categorization. Nonsignificant variables (P<0.05) were removed from the model by backward elimination.
Complete data were available for all variables in the SSNAP data set apart from the full NIHSS score on admission, which was available for 76% of patients. A total of 373 patients with unspecified stroke type were not included. Two models were therefore fitted: 1 including the NIHSS (model A) and 1 including only the NIHSS level of consciousness component (model B), because this was available for 100% of patients.
The accuracy of the mortality predictions generated in the final models was assessed in the internal and validation data sets. The coefficients and variables from each of the models were used to calculate the predicted probability of death for each patient in the internal and validation data sets. Discrimination was assessed by receiver operating characteristic curve analysis and estimation of the c-statistic. Calibration was visually assessed using calibration plots, grouping patients into deciles of predicted mortality risk. The observed and predicted mortality rates were plotted by deciles of predicted risk. The correlation between observed and predicted mortality rates were assessed in scatter plots and the Pearson correlation coefficient estimated. Given the large sample sizes used in this study, we did not use Hosmer and Lemeshow goodness-of-fit tests to assess calibration, because the test is recognized to be sensitive to sample size. 11 Analyses were performed in Stata 12 MP (Stata Corp).
Results
Data were available for 27 169 patients with acute stroke in the SSNAP data set and 1470 patients in the SLSR data set. The median age was higher in the derivation (77 years; interquartile range [IQR], 67-85 years) and internal validation data sets (77 years; IQR, 67-85 years) compared with the external validation data set (72 years; IQR, 59-81; Kruskal-Wallis P=0.0001; Table 1 ). There were also statistically significant differences in the distribution of stroke types between SSNAP and the SLSR. The proportion of ischemic strokes was 89.5%, 89.6%, and 86.3% in the derivation, internal validation, and external validation data sets, respectively. Atrial fibrillation was more frequent in the SSNAP data set (20.3% and 20.4%) than in the SLSR (16.7%; χ 2 P=0.003). Stroke severity was also overall lower in the derivation and internal validation data sets (median NIHSS, 4; IQR, 2-10 in both) than in the external validation data set (median NIHSS, 6; IQR, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Thirtyday mortality rates also differed significantly: 13.2% in the derivation, 12.0% in the internal validation, and 15.3% in the external validation groups (χ 2 P<0.0001). The variables and coefficients of the 2 final models that were developed from the derivation data set are shown in Table 2 . Model A included age in 5 categories (<60, 60-69, 70-79, 80-89 and ≥90 years), NIHSS on admission, the presence of atrial fibrillation, and stroke type (ischemic or primary ICH). Model B was similar but included the 4 levels of the NIHSS consciousness component.
Both models A and B showed good discrimination in both the SSNAP and SLSR validation data sets (Figure 1 Table 3 ). Both models also were well calibrated across the whole range of mortality risk (Figures 2 and 3 ; see online-only Data Supplement), correctly classifying patients across a wide range of mortality risk. In external validation, model A tended to predict lower mortality in the highest risk patients than was observed in the external validation cohort but overall observed mortality scaled appropriately across deciles of predicted risk. Both models showed a high degree of correlation 
Discussion
We have derived and validated 2 simple models to predict 30-day mortality in unselected patients admitted with acute stroke to hospitals in the United Kingdom. One model uses the complete NIHSS on admission and the other uses the 4 levels of the NIHSS consciousness component. Both models showed good discrimination and were well calibrated in internal and external data sets, although the model including the full NIHSS score demonstrated slightly better discrimination. The variables included in the models are likely to be collected routinely on patients with stroke in many healthcare settings and so potentially have wide applicability. In settings where training or resources limit the collection of the full NIHSS, information on consciousness level provides a good proxy for the full NIHSS in predicting 30-day mortality.
The study was not intended to provide new insight into the epidemiology of stroke: it is well recognized that older age, higher NIHSS, hemorrhagic stroke, and atrial fibrillation are all associated with worse prognosis. 12, 13 Atrial fibrillation is a marker for cardioembolic stroke, which is associated with the poorest outcomes in ischemic stroke. 14 In the current study, atrial fibrillation was also a predictor for higher mortality in ICH. The reason for this is not clear, but it may be that anticoagulation-associated ICH is associated with poor outcomes or that atrial fibrillation is a marker for cardiovascular comorbidity.
The main contribution of this study is that it developed relatively simple and parsimonious models to make accurate predictions of the risk of 30-day mortality in unselected populations of stroke. Because they use variables routinely recorded during the assessment of patients with stroke and have been validated in both ischemic and ICH stroke, the models are likely to be comparatively straightforward to implement in the comparison of mortality rates between stroke care providers. Developing standardized and validated methods for adjusting mortality rates is essential when comparing the outcomes of stroke services so that apparent variation does not just reflect differences in case mix.
A variety of models have been developed previously to predict outcomes after stroke. A recent systematic review identified 17 models derived and externally validated in stroke cohorts. 4 More recent studies have generated ≥1 further externally validated model. 5 Seven of these models predict 
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November 2014 mortality after stroke. As with the models developed in this study, most include age and some measure of stroke severity.
The most widely validated model is the simple six variable (SSV) model, 15 which includes age, living alone, independence prestroke, Glasgow coma scale verbal score, ability to lift both arms, and ability to walk. The discrimination of the models derived in the present study is similar to that reported for the simple six variable, which has been found in external validation to have a c-statistic of 0.73 to 0.86. [15] [16] [17] A more recently developed model to predict outcomes is the iScore, which has been externally validated in cohorts from several countries. 18, 19 In addition to age and stroke severity (measured by the Canadian Neurological Scale), it includes comorbidity, serum glucose level, and prestroke dependence. Discrimination of the iScore is good and again similar to the models developed in this study, with c-statistics of 0.85 to 0.87 5, 18, 19 ; however, it has only been validated in patients with ischemic stroke. Several previous studies have incorporated the NIHSS 13, 20 and demonstrated the strong association of this scale with stroke outcomes. In the United Kingdom, commonly used mortality measures for stroke care (eg, Dr Foster Intelligence) 21 use administrative data. These are however limited in that routine coding contains no information on stroke severity and the models have not been externally validated in stroke: their accuracy is therefore unclear and likely to be less than models based on clinical data sets.
One of the strengths of the study was that the models were validated in a cohort of patients identified in a population-based register. The cohort is therefore more likely to truly represent a population of unselected patients with stroke than cohorts from other sources, such as randomized controlled trials or patients identified through routine administrative coding. In addition, the characteristics of the patients in the external data set differed significantly from the derivation data set. The differences in the populations between the SLSR and SSNAP might reflect that the SLSR data are from an earlier time period, more complete ascertainment in the population-based SLSR, or the relatively young, multiethnic inner city population of the SLSR denominator population. 10 That the models made almost as accurate predictions in a stroke population with different characteristics than were used to derive the models increases the external validity of the models. Another advantage of the study is that both the derivation and validation data sets included unselected patients with ischemic stroke or primary ICH, and thus is likely to be more representative of the broad range of patients with stroke admitted to hospital. The sample size was large (larger than the sum total of all 17 previous studies identified in systematic review), 4 includes patients admitted with acute stroke to all hospitals in England and Wales, and reflects the outcomes of contemporary stroke care. Many of the previously developed models were based on data from single sites 22 or interventional cohorts, 6, 23 or were derived from historic cohorts 24 of patients who had stroke at a time before the widespread use of interventions proven to improve outcomes after stroke, such as organized stroke unit care. 25 The validity of these models in predicting the outcomes of contemporary patients with stroke is therefore uncertain.
Limitations
The models were derived on data collected during routine care, and although participating teams are encouraged to enter data on all consecutive stroke admissions, we cannot exclude selection bias in the sample. Ideally models are validated in a prospective cohort specifically set up to test the validity of the model. One weakness is therefore that we used a retrospective cohort for external validation. Both samples were drawn from the UK population and external validation in other settings would be important to consider before using the models elsewhere, particularly in populations with a higher rate of ICH. Mortality outcomes were limited to all-cause mortality and did not take into account clinical decisions that might contribute to mortality rates, such as withdrawal of active treatment. The choice of variables to be included in the models was determined by their availability in SSNAP; some potentially important variables that may have improved the precision of the model (eg, levels of comorbidity) were not available. Patients with undetermined stroke type were not included in the model, and therefore these models may not be suitable for use in lowincome countries where it may not be possible to determine whether the stroke was ischemic or the result of a primary ICH.
Conclusions
This study has derived and externally validated 2 new models to predict 30-day mortality after stroke, using a large sample of contemporary patients with stroke. They show good accuracy in predicting 30-day mortality in unselected patients with ischemic stroke or primary ICH, are simple to calculate and use variables that are recorded on admission in many stroke centers. These prognostic models permit the validated comparison of adjusted 30-day mortality outcomes between stroke centers in the United Kingdom.
